Yi Zhang | Health Sciences | Best Researcher Award

Posted on 14/11/202414/11/2024 by sciencefatherLeave a Comment

Prof. Yi Zhang | Health Sciences | Best Researcher Award

Director/Academic Vice President at Biotherapy Center, The First Affiliated Hospital of Zhengzhou University/Zhengzhou University School of Medical Sciences🎓

Prof. Yi Zhang is an internationally acclaimed expert in cell and tumor immunotherapy. Serving as Director of the Biotherapy Center at The First Affiliated Hospital of Zhengzhou University, he also holds key leadership roles, including Academic Vice President of the Zhengzhou University School of Medical Sciences and Director of the Zhongyuan Cellular and Immunotherapy Laboratory. With 35 years of research experience across Belgium, the U.S., and China, Prof. Zhang has pioneered breakthrough therapies, such as genetically engineered CAR-T cells for solid tumors, and holds 16 patents. His work has made significant impacts in reducing immune suppression and improving cancer treatment efficacy worldwide.

Professional Profile

ORCID

Education 🎓:

Prof. Yi Zhang has a profound academic foundation in medical sciences, gained through decades of experience and study in Belgium, the United States, and China. His extensive education and training have built the groundwork for his pioneering research in cell and tumor therapy.

Work Experience 💼:

Prof. Zhang is the Director of the Biotherapy Center at The First Affiliated Hospital of Zhengzhou University, where he also serves as the Academic Vice President for Zhengzhou University’s School of Medical Sciences and Director of the Zhongyuan Cellular and Immunotherapy Laboratory. Over a 35-year career, he has developed innovative therapies and led cutting-edge research in cell therapy, accumulating extensive clinical and academic expertise.

Skills 🔍

Known for his skills in genetically engineered cell therapies, Prof. Zhang is a leader in cellular engineering, particularly CAR-T cell technology. His groundbreaking work includes discovering a therapeutic target for solid tumors and developing gene-editing techniques to improve immune responses. His practical expertise in cell culture, immune cell enhancement, and patent development make him a pioneer in clinical biotherapeutics.

Awards and Honors 🏆

Prof. Zhang has received acclaim globally, being listed among the world’s top 100,000 scientists and recognized by both domestic and international peers for his contributions to immunotherapy. He has successfully converted seven patents, raising over 80 million RMB in transfer amounts, and is frequently invited to international conferences as a distinguished chair or guest of honor.

🤝 Memberships:

Prof. Zhang holds numerous prominent roles, such as Chairman of the Committee on Tumor Immunity and Biotherapy, Chinese Society of Immunology, and Deputy Chairman of the Cancer Biological Therapy Committee under the China Anti-Cancer Association. He also plays leadership roles in the Henan Anticancer Association and Henan Immunological Society, reflecting his commitment to advancing cell therapy on a national and global scale.

Teaching Experience 👩‍🏫:

Prof. Zhang has contributed significantly to training the next generation of scientists, collaborating with international colleagues to co-train PhD students and mentor young researchers. His commitment to academic growth is evident through his regular academic exchanges and collaborative projects with institutions in Canada, the U.S., and Europe.

Research Focus 🔬:

Prof. Zhang’s research is concentrated on tumor immunotherapy and cellular therapy, focusing on advancing CAR-T cell therapies for cancer. His achievements include creating novel immune cell treatments, reducing PD-1 expression to combat immune suppression, and conducting over 52 clinical trials for new cancer therapies, with 29 specifically targeting solid tumors.

Conclusion

Prof. Yi Zhang stands as an exemplary candidate for the Best Researcher Award due to his substantial contributions to the field of cellular immunotherapy and cancer research. His achievements align closely with the award’s goals of recognizing innovation, impactful research, and contributions to society. With his strengths in pioneering therapy innovations and significant clinical applications, Prof. Zhang’s work exemplifies the award’s spirit, making him a distinguished candidate for the Best Researcher Award.

📚 Publilcation

“LFA-1 regulated by IL-2/STAT5 pathway boosts antitumor function of intratumoral CD8 + T cells for improving anti-PD-1 antibody therapy”
- Year: 2024-12-31
- Journal: OncoImmunology
“Characteristics and mechanisms of T‐cell senescence: A potential target for cancer immunotherapy”
- Year: 2024-11
- Journal: European Journal of Immunology
“CAR T Cells Engineered to Secrete IFNκ Induce Tumor Ferroptosis via an IFNAR/STAT1/ACSL4 Axis”
- Year: 2024-10-03
- Journal: Cancer Immunology Research
“A single-cell RNA-seq dataset describing macrophages in NSCLC tumor and peritumor tissues”
- Year: 2024-10-01
- Journal: Scientific Data
“Allogeneic CAR-T cells for cancer immunotherapy”
- Year: 2024-09-24
- Journal: Immunotherapy
“IL-24 improves efficacy of CAR-T cell therapy by targeting stemness of tumor cells”
- Year: 2024-05-03
- Journal: British Journal of Cancer
“Current advances in bacteria‐based cancer immunotherapy”
- Year: 2024-02
- Journal: European Journal of Immunology
“Emerging roles of plasmacytoid dendritic cell crosstalk in tumor immunity”
- Year: 2023-10-09
- Journal: Cancer Biology & Medicine
“Immunosenescence: molecular mechanisms and diseases”
- Year: 2023-05-13
- Journal: Signal Transduction and Targeted Therapy
“Overcoming resistance to immunotherapy by targeting GPR84 in myeloid-derived suppressor cells”
- Year: 2023-04-28
- Journal: Signal Transduction and Targeted Therapy

Layla J.R Al-Mansoori | Biomedical | Best Research Award

Posted on 11/11/202411/11/2024 by sciencefatherLeave a Comment

Layla J.R Al-Mansoori | Biomedical | Best Research Award

Biomedical Research CenterThis link is disabled., Doha, Qatar🎓

Dr. Layla J.R Al-Mansoori is a Research Assistant Professor at the Biomedical Research Center, Qatar University. She holds a Bachelor’s degree in Biomedical Science from Qatar University and a Master of Science in Biochemistry from King Saud University. Layla earned her PhD in Medicine from Groningen University, Netherlands, focusing on targeted cancer treatments and long-acting protein therapeutics. Her research expertise includes cancer therapy, insulin resistance, stem cell differentiation, and bioengineering. Layla is an active researcher and supervisor, contributing to multiple national and international projects and grants. She is also involved in teaching and mentoring MSc and PhD students in biomedical sciences

Professional Profile

Scopus

Education 🎓:

Layla J.R Al-Mansoori has a distinguished academic background. She obtained her Bachelor’s degree in Biomedical Science from Qatar University in 1999. She further advanced her studies by completing a Master of Science (MSc) in Biochemistry from King Saud University, Saudi Arabia, in 2010, where she focused on the molecular mechanisms of Ukrain and Taxotere in breast cancer cells. Her academic journey continued with a PhD program in Laboratory Medicine and Pathobiology at the University of Toronto, Canada, where she researched embryonic stem cells and their differentiation into osteogenic lineage. Layla completed her PhD in 2020 at Groningen University in the Netherlands, with a project on “Ligand Directed Enzyme Prodrug Therapy and Production of Long-Acting Protein Therapeutics for Targeted Cancer Treatment.”

Work Experience 💼:

Dr. Layla J.R Al-Mansoori currently serves as a Research Assistant Professor at the Biomedical Research Center at Qatar University. Her work focuses on biomedical research, particularly in the field of cancer treatment and therapeutics. She has worked extensively in various research labs, including her PhD research, which focused on enzyme prodrug therapy and targeted cancer treatments. She has also been involved in multiple research projects, including supervising MSc and PhD students, and contributing to national and international research grants.

Skills 🔍

Layla possesses a strong set of laboratory and research skills, particularly in the fields of molecular biology, biochemistry, and stem cell research. Her expertise extends to stem cell maintenance, differentiation, enzyme prodrug therapies, and the development of long-acting protein therapeutics. She is also highly skilled in grant writing, project management, and research supervision.

Awards and Honors 🏆

Throughout her career, Layla has been the recipient of numerous grants and honors, including multiple QU Student Grants, UREP grants from QNRF, and participation in national capacity building projects. She has been recognized for her innovative research on cancer therapies, insulin resistance, and bioactive glass scaffolds for bone regeneration. Her involvement in high school research programs also highlights her contribution to nurturing young talent in the biomedical sciences.

🤝 Memberships:

Dr. Al-Mansoori is an active member of several professional research organizations. Her collaborations extend across national and international research communities, where she contributes to projects on cancer therapy, diabetes, and bioengineering.

Teaching Experience 👩‍🏫:

Layla has significant teaching experience, particularly in supervising MSc and PhD students. She serves as a committee member for MSc students working on epigenetic regulation and obesity treatments, and she co-supervises PhD students investigating cancer biomarkers. Her teaching role is integral to the development of future scientists in Qatar.

Research Focus 🔬:

Dr. Al-Mansoori’s research focuses on cancer therapeutics, with particular interest in ligand-directed enzyme prodrug therapy, protein therapeutics, and insulin resistance. She has also explored the role of exosomes in cancer biomarkers and the use of bioactive glass scaffolds for bone regeneration. Her work aims to improve targeted treatments for cancer, enhance drug delivery systems, and further understand metabolic disorders like diabetes.

Conclusion

Dr. Layla J.R Al-Mansoori demonstrates a compelling case for the Best Researcher Award due to her pioneering research in cancer therapy, her leadership in academic mentorship, and her contributions to the scientific community. With her dedication to advancing medical treatments and improving health outcomes, she is a deserving candidate for this prestigious award

📚 Publilcation

MLIP and Its Potential Influence on Key Oncogenic Pathways
- Authors: Hamwi, M.N., Elsayed, E., Dabash, H., Al-Mansoori, L., Burgon, P.G.
- Year: 2024
- Journal: Cells
- Volume: 13(13), 1109
The Association between Lifestyle Factors and COVID-19: Findings from Qatar Biobank
- Authors: Akbar, Z., Kunhipurayil, H.H., Saliba, J., Shi, Z., Shaito, A.A.
- Year: 2024
- Journal: Nutrients
- Volume: 16(7)
Impact of Obesity-Related Endoplasmic Reticulum Stress on Cancer and Associated Molecular Targets
- Authors: AlBashtawi, J., Al-Jaber, H., Ahmed, S., Al-Mansoori, L.
- Year: 2024
- Journal: Biomedicines
- Volume: 12(4), 793
The Role of Apolipoproteins in the Commonest Cancers: A Review
- Authors: Darwish, N.M., Al-Hail, M.K., Mohamed, Y., Al-Mansoori, L., Pedersen, S.
- Year: 2023
- Journal: Cancers
- Volume: 15(23), 5565
Evaluation of the Influence of Eggshell (ES) Concentration on the Degradation Behavior of Mg-2.5Zn Biodegradable Alloy in Simulated Body Fluid
- Authors: Radwan, A.B., Okonkwo, P.C., Murugan, S., Shakoor, R.A., Abdullah, A.M.
- Year: 2023
- Journal: ACS Biomaterials Science and Engineering
- Volume: 9(5), pp. 2376–2391
Effect of Sera from Elite Athletes on Cytokine Secretion and Insulin Signaling in Preadipocytes and Skeletal Muscle Cells
- Authors: Alheidous, S., Al-Muraikhy, S., Rizk, N., Al-Mansoori, L., Elrayess, M.A.
- Year: 2022
- Journal: Frontiers in Molecular Biosciences
- Volume: 9, 943034
In Vitro and In Vivo Validation of GATA-3 Suppression for Induction of Adipogenesis and Improving Insulin Sensitivity
- Authors: Al-Jaber, H., Mohamed, N.A., Govindharajan, V.K., Al-Mansoori, L., Elrayess, M.A.
- Year: 2022
- Journal: International Journal of Molecular Sciences
- Volume: 23(19), 11142
Role of Inflammatory Cytokines, Growth Factors, and Adipokines in Adipogenesis and Insulin Resistance
- Authors: Al-Mansoori, L., Al-Jaber, H., Prince, M.S., Elrayess, M.A.
- Year: 2022
- Journal: Inflammation
- Volume: 45(1), pp. 31–44
Bio-vehicles of Cytotoxic Drugs for Delivery to Tumor Specific Targets for Cancer Precision Therapy
- Authors: Al-Mansoori, L., Elsinga, P., Goda, S.K.
- Year: 2021
- Journal: Biomedicine and Pharmacotherapy
- Volume: 144, 112260
Age and Sport Intensity-dependent Changes in Cytokines and Telomere Length in Elite Athletes
- Authors: Sellami, M., Al-Muraikhy, S., Al-Jaber, H., Botre, F., Elrayess, M.A.
- Year: 2021
- Journal: Antioxidants
- Volume: 10(7), 1035

Dr.Bahareh Azimi | biomedical | Best Researcher Award

Posted on 25/10/202425/10/2024 by sciencefatherLeave a Comment

Dr.Bahareh Azimi | biomedical | Best Researcher Award

PhD Scholar at Chitkara University, India

Dr. Bahareh Azimi is a distinguished researcher in the field of Textile Engineering, specializing in Textile Chemistry and Fiber Science. With a passion for advancing materials science applications in medicine, she focuses on developing innovative therapeutic strategies using polymeric nanofibers and nanoparticles. Her research is dedicated to improving health outcomes through cutting-edge technology and materials.

Professional Profile

scopus

🎓 Education

Dr. Bahareh Azimi holds a Ph.D. in Textile Engineering with a focus on Textile Chemistry and Fiber Science from Amirkabir University of Technology, completed between September 23, 2010, and November 23, 2014, in Tehran, Iran. She also has an equivalent Ph.D. in Industrial Engineering (Curriculum in Chemistry and Materials Engineering) issued by the University of Pisa, Italy. Additionally, Dr. Azimi earned her Master’s Degree in Textile Engineering (Textile Chemistry and Fiber Science) from Amirkabir University of Technology from September 23, 2007, to October 24, 2009, and completed her Bachelor’s degree in the same field at the University of Yazd from September 23, 2003, to September 6, 2007.

🏢 Work Experience

Dr. Azimi is currently a postdoctoral researcher at the Department of Civil and Industrial Engineering at the University of Pisa since September 16, 2024. Her previous roles include a postdoctoral position in the Department of Surgical, Medical, Molecular, and Critical Area Pathology at the University of Pisa, where she focused on manufacturing and characterizing piezoelectric polymer nanofibers for cochlear implants. She has also worked on circular management of operating room waste in orthopedics and traumatology and has contributed to various projects involving the production of polymeric and composite nanofibers. Notably, she was a postdoctoral researcher at the Brazilian National Research Council, where she developed polymeric films with luminescent nanocrystals for dosimetric applications.

🧬 Skills

Dr. Azimi possesses advanced skills in electrospinning technology, materials characterization, and the development of biomimetic scaffolds. Her expertise extends to polymer and composite materials for tissue engineering applications, particularly in regenerative medicine. She is proficient in both experimental and theoretical methodologies, allowing her to address complex biomedical challenges effectively.

Awards and Honors 🏆

In 2024, Dr. Azimi received funding for her project titled “Artificial Intelligence Enabled Electrospinning Approach to Fight Pulmonary Cancer” through the Marie Skłodowska-Curie Actions-Seal of Excellence@UNIPI. This recognition underscores her innovative contributions to research and her commitment to addressing significant health challenges.

Membership 🤝

Dr. Azimi is an active member of various professional organizations related to Textile Engineering and materials science. Her memberships facilitate collaboration with peers and access to the latest advancements in her field, contributing to her continuous professional development.

Teaching Experience 📚

Dr. Azimi has experience in teaching and mentoring students in Textile Engineering, focusing on subjects related to textile chemistry and materials science. Her engaging teaching style and dedication to student success have made her a respected educator in her academic community.

🔬 Research Focus

Dr. Azimi’s current research includes developing biomimetic scaffolds for tissue regeneration, nanoparticle-mediated drug delivery systems for targeted therapy, and electroactive nanocomposites for electromechanical tissue engineering, particularly in the auditory system. She has been actively involved in nanomedicine, particularly exploring in vitro applications of piezoelectric ceramic nanomaterials such as zinc oxide, lithium niobate, and barium titanate nanoparticles, as well as their polymer composites for creating electrically sensitive cells. Her comprehensive research also addresses the development of devices from nano to macroscale, aimed at facilitating regeneration and modeling both normal and pathological tissues, with an emphasis on tissue engineering applied to electromechanically responsive tissues.

Conclusion

Dr. Bahareh Azimi’s extensive research contributions, innovative methodologies, and dedication to advancing biomedical applications through materials science make her a strong candidate for the Best Researcher Award. Her work has the potential to significantly enhance health outcomes, particularly in the fields of tissue engineering and regenerative medicine. By addressing areas for improvement, such as public engagement and interdisciplinary collaboration, Dr. Azimi can further amplify her impact and leadership in research, reinforcing her candidacy for this prestigious recognition.

📚 Publication

Antifouling Properties of Electrospun Polymeric Coatings Induced by Controlled Surface Morphology
- Authors: Favrin, F.L., Zavagna, L., Sestini, M., Batoni, G., Danti, S.
- Year: 2024
- Journal: Energy and Environmental Materials
Electrospun Fiber-Based Tubular Structures as 3D Scaffolds to Generate In Vitro Models for Small Intestine
- Authors: Zavagna, L., Canelli, E.F., Azimi, B., Milazzo, M., Danti, S.
- Year: 2024
- Journal: Macromolecular Materials and Engineering
Development and Characterization of Sodium Alginate-Based Bio-hybrid Super Absorbent Polymer with High Retention Capacity Suitable for Baby Diapers
- Authors: Ismaeilimoghadam, S., Jonoobi, M., Hamzeh, Y., Seggiani, M., Danti, S.
- Year: 2024
- Journal: Journal of Polymers and the Environment
Piezoelectric Yield of Single Electrospun Poly(acrylonitrile) Ultrafine Fibers Studied by Piezoresponse Force Microscopy and Numerical Simulations
- Authors: Montorsi, M., Zavagna, L., Scarpelli, L., Danti, S., Labardi, M.
- Year: 2024
- Journal: Polymers
Remnant polarization and structural arrangement in P(VDF-TrFE) electrospun fiber meshes affect osteogenic differentiation of human mesenchymal stromal cells
- Authors: Azimi, B., Labardi, M., Sorayani Bafqi, M.S., Persano, L., Danti, S.
- Year: 2024
- Journal: Materials and Design
Recent advances in biomaterials for tissue-engineered constructs: Essential factors and engineering techniques
- Authors: Norouzi, S., Saveh Shemshaki, N., Norouzi, E., Aboudzadeh, M.A., Bagherzadeh, R.
- Year: 2024
- Journal: Materials Today Chemistry
Bacterial Cellulose Electrospun Fiber Mesh Coated with Chitin Nanofibrils for Eardrum Repair
- Authors: Azimi, B., Rasti, A., Fusco, A., Danti, S., Lazzeri, A.
- Year: 2024
- Journal: Tissue Engineering – Part A
Self-Powered Nanostructured Piezoelectric Filaments as Advanced Transducers for New Cochlear Implants
- Authors: Mokhtari, F., Danti, S., Azimi, B., Varley, R.J., Razal, J.M.
- Year: 2024
- Journal: Energy and Environmental Materials
Emerging Multiscale Biofabrication Approaches for Bacteriotherapy
- Authors: Rovelli, R., Cecchini, B., Zavagna, L., Batoni, G., Danti, S.
- Year: 2024
- Journal: Molecules
Application of Cellulose-Based Materials as Water Purification Filters; A State-of-the-Art Review
- Authors: Azimi, B., Sepahvand, S., Ismaeilimoghadam, S., Jonoobi, M., Danti, S.
- Year: 2024
- Journal: Journal of Polymers and the Environment

Dr YUKSEL ÇETİN | Functional Biomaterials | Best Researcher Award

Posted on 25/09/202425/09/2024 by sciencefatherLeave a Comment

Dr YUKSEL ÇETİN | Functional Biomaterials | Best Researcher Award

Chief Researcher at The Scientific and Technological Research Council (TUBITAK), Marmara Research Center (MAM)🎓

Dr. Yüksel Çetin is the Chief Researcher at the Life Sciences, Medical Biotechnology Unit of TUBITAK’s Marmara Research Centre, Turkey. He earned his PhD in Food Science and Technology from the University of Nebraska-Lincoln, with a minor in Toxicology. His postdoctoral work focused on pulmonary disease pathogenesis through the FP 6 PULMONET project. Yüksel specializes in in vivo and in vitro toxicology, studying novel drugs, biomaterials, and nanoparticles. He leads several funded projects, including NANOBIO4CAN for cancer therapies and the development of 3D cardiac patches. His commitment to innovation and safety in biotechnology highlights his significant contributions to the field.

Professional Profile

Google Scholar

Education 🎓

Yüksel Çetin earned his PhD in Food Science and Technology from the University of Nebraska-Lincoln, USA, with a minor in Toxicology from the Toxicology Centre for Environmental Toxicology at the Eppley Institute for Research in Cancer and Allied Diseases. His postdoctoral research focused on the pathogenesis of pulmonary disease through the FP 6 PULMONET Marie Curie Project at the European Commission’s Joint Research Centre.

Work Experience 🏢

Currently serving as Chief Researcher at the Life Sciences, Medical Biotechnology Unit of the Scientific & Technological Research Council of Turkey (TUBITAK) at the Marmara Research Centre, Yüksel has held multiple leadership roles in various research projects, overseeing significant budgets and collaborative efforts aimed at advancing medical biotechnology and toxicology.

Skills 🔬

Yüksel possesses extensive expertise in in vivo and in vitro toxicology, molecular mechanisms of drugs, biomaterials, and medical devices. His proficiency in three-dimensional bioprinting technology and nanoparticle research is complemented by a robust background in evaluating the pathogenicity of xenobiotics.

Awards and Honors 🏆

He has been recognized for his innovative contributions to medical biotechnology and has received multiple grants and funding for his research projects, underlining his reputation as a leader in the field.

Membership 🌍

Yüksel is an active member of various scientific organizations and advisory boards, including involvement in Horizon 2020 projects focused on nanotechnology and safety assessments, emphasizing his commitment to advancing scientific research and innovation.

Teaching Experience 👨‍🏫

With a wealth of knowledge, Yüksel has shared his expertise through teaching roles at various academic institutions, focusing on topics related to food science, toxicology, and medical biotechnology, mentoring the next generation of scientists.

Research Focus 🔍

His research primarily investigates the toxicological effects of novel drugs, biomaterials, and nanoparticles, as well as the development of innovative therapeutic approaches for cancer treatment. Yüksel’s projects encompass antiviral research, tissue regeneration, and vaccine development, demonstrating his dedication to impactful scientific advancements.

Publications :

Cytotoxicity of Fusarium mycotoxins to mammalian cell cultures as determined by the MTT bioassay
Year: 2005
Journal: Food and Chemical Toxicology
In vitro evaluation of the toxicity induced by nickel soluble and particulate forms in human airway epithelial cells
Year: 2011
Journal: Toxicology in vitro
Evaluation of reduced toxicity of zearalenone by extrusion processing as measured by the MTT cell proliferation assay
Year: 2005
Journal: Journal of Agricultural and Food Chemistry
Characterisation of cadmium chloride induced molecular and functional alterations in airway epithelial cells
Year: 2009
Journal: Cellular Physiology and Biochemistry
Evaluation of the molecular mechanisms of a palladium (II) saccharinate complex with terpyridine as an anticancer agent
Year: 2014
Journal: Anti-Cancer Drugs
A novel system to study the impact of epithelial barriers on cellular metabolism
Year: 2000
Journal: Annals of Biomedical Engineering
Confirmation of reduced toxicity of deoxynivalenol in extrusion-processed corn grits by the MTT bioassay
Year: 2006
Journal: Journal of Agricultural and Food Chemistry
The neutralization effect of montelukast on SARS-CoV-2 is shown by multiscale in silico simulations and combined in vitro studies
Year: 2022
Journal: Molecular Therapy
The Development of Novel Approaches to the Identification of Chemical and Protein Respiratory Allergens: Progress made from the Conclusions and Recommendations of ECVAM Workshop 60
Year: 2008
Journal: Alternatives to Laboratory Animals
Fabrication of a dual-drug-loaded smart niosome-g-chitosan polymeric platform for lung cancer treatment
Year: 2023
Journal: Polymers
Instant determination of the artemisinin from various Artemisia annua L. extracts by LC‐ESI‐MS/MS and their in‐silico modelling and in vitro antiviral activity
Year: 2022
Journal: Phytochemical Analysis
A palladium (II)–saccharinate complex of terpyridine exerts higher anticancer potency and less toxicity than cisplatin in a mouse allograft model
Year: 2017
Journal: Anti-Cancer Drugs